American Journal

The American Journal of Managed Care® announces call for manuscript submissions for the 14th Annual Health Information Technology Special Issue

Retrieved on: 
星期二, 四月 23, 2024

CRANBURY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, today announced that it is seeking manuscript submissions for its 14th Annual Health Information Technology (IT) Special Issue, with a deadline of July 31, 2024.

Key Points: 
  • CRANBURY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, today announced that it is seeking manuscript submissions for its 14th Annual Health Information Technology (IT) Special Issue, with a deadline of July 31, 2024.
  • “Having been acknowledged as an expert in health care management and information technology, Lyles brings invaluable insight.
  • We’re certain that with her guidance, this special issue will become an invaluable resource for both health care professionals and researchers."
  • “The Health IT Special Issue published by AJMC is so important, especially in light of the ever-increasing pace of digital innovation,” Lyles said.

XORTX Announces Publication of Key Research in ADPKD

Retrieved on: 
星期一, 四月 22, 2024

This study shows, for the first time, that chronically increased SUA can significantly increase cyst index and increase kidney size in ADPKD.

Key Points: 
  • This study shows, for the first time, that chronically increased SUA can significantly increase cyst index and increase kidney size in ADPKD.
  • Dr. Allen Davidoff, CEO of XORTX, stated, “We are pleased to have supported this pioneering research in polycystic kidney disease by Dr. Charles Edelstein of the University of Colorado.
  • In human ADPKD, kidney size and declining kidney filtering capacity are correlated and are key indicators of disease progression and prognosis.
  • These mechanistic studies are important for the planning of future clinical studies of xanthine oxidase inhibition in patients with ADPKD.”

Flexible morals: A key reason American voters support divisive misinformation

Retrieved on: 
星期二, 四月 16, 2024

A common assumption about the problem is that partisan voters are apt to believe what they should question (and vice versa).

Key Points: 
  • A common assumption about the problem is that partisan voters are apt to believe what they should question (and vice versa).
  • And research backs up the idea that voters are “factually flexible,” either due to laziness or bias .
  • What if a key part of the story is that partisan voters are also “morally flexible” — that they hold opposition politicians to strict standards of factuality but allow their favorite politicians to share misinformation — even socially divisive misinformation.
  • For morally flexible voters, such statements are permissible because they articulate a “deeper truth” that captures their grievances.

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2

Retrieved on: 
星期三, 四月 10, 2024

OMNI facilitates a unique implant-free, ab interno procedure that comprehensively addresses the three primary areas of resistance in the conventional outflow pathway.

Key Points: 
  • OMNI facilitates a unique implant-free, ab interno procedure that comprehensively addresses the three primary areas of resistance in the conventional outflow pathway.
  • OMNI technology has been cleared by the FDA for canaloplasty followed by trabeculotomy to reduce intraocular pressure in adult patients with primary open-angle glaucoma.
  • The primary treatment goal for the high baseline IOP group (> 18mmHg) was IOP reduction, with a secondary goal to reduce medication burden.
  • The primary treatment goal for the low baseline IOP group (

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study

Retrieved on: 
星期三, 四月 10, 2024

“Each year 36,000 babies in the United States suffer neurological damage, which could be prevented through better monitoring tools, such as Lumerah,” says Raydiant Oximetry founder and CEO, Dr. Neil P. Ray.

Key Points: 
  • “Each year 36,000 babies in the United States suffer neurological damage, which could be prevented through better monitoring tools, such as Lumerah,” says Raydiant Oximetry founder and CEO, Dr. Neil P. Ray.
  • Lumerah has received FDA Breakthrough Device Designation for expedited market approval.
  • Completion of the EFS study will pave the path towards FDA IDE approval for a subsequent pivotal study.
  • Raydiant Oximetry is supported by leading organizations that include the March of Dimes and the National Institutes of Health (NIH).

New Research from VillageMD Finds Regular Primary Care Visits Decrease Hospitalizations

Retrieved on: 
星期三, 四月 17, 2024

A new study published in The American Journal of Managed Care demonstrates the value of high-cadence primary care visits in reducing hospitalizations among high-risk patients.

Key Points: 
  • A new study published in The American Journal of Managed Care demonstrates the value of high-cadence primary care visits in reducing hospitalizations among high-risk patients.
  • The research was conducted by VillageMD Research Institute and is titled, “Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients.” Researchers found that quarterly primary care visits through Village Medical’s Stay Well Care Plan provided an opportunity to lower hospitalizations.
  • “As a primary care physician, I am heartened but not surprised by the results of this study,” said Clive Fields, M.D., co-founder and chief medical officer, VillageMD.
  • “High-quality primary care can keep patients healthier and out of the hospital, so continuity and regularity of care demonstrates the need for these quality metrics.

Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care

Retrieved on: 
星期一, 四月 15, 2024

This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.

Key Points: 
  • This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.
  • Leslie Trigg, Chair and CEO of Outset, shared her thoughts on the partnership: “We enthusiastically support ANNA’s goal of empowering and educating nephrology nurses who are essential to delivering high-quality care to patients with kidney disease.
  • This partnership demonstrates our dedication to enhancing patient outcomes and supporting the vital role of the nephrology nurses who care for them.”
    ANNA emphasized the importance of collaboration with industry leaders to advance the nephrology nursing field.
  • “Outset Medical’s support, together with our other corporate partners, is important to our mission,” said Michele Kimball, ANNA Executive Director.

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Retrieved on: 
星期四, 四月 18, 2024

NEW YORK, April 18, 2024 /PRNewswire/ -- A new study by surgeon-scientists at Hospital for Special Surgery (HSS) found that 25% of patients with hip impingement who underwent modern arthroscopy for their condition experienced a delay in the natural progression of osteoarthritis. The retrospective study, published online on March 8, 2024, in The American Journal of Sports Medicine, is the first to link hip arthroscopy with a reduced risk of developing hip arthritis over the long term.

Key Points: 
  • Hip impingement occurs when the bones of the hip joint are not shaped properly, causing them to rub against one another.
  • Prior studies have shown that 85-90% of patients with hip impingement who undergo modern arthroscopy return to their usual activity level.
  • "By contrast, we studied the effect of modern arthroscopic methods by comparing the degree of arthritis in each patient's operative hip versus their nonoperative hip.
  • For ideal candidates, the evidence shows that hip arthroscopy may delay or prevent arthritis for one in four patients.

Current constipation medications don't provide relief for some patients with Chronic Idiopathic Constipation, per Gastroenterologist survey

Retrieved on: 
星期二, 四月 9, 2024

The survey of roughly 100 high-volume gastroenterology providers found that 74 percent of those interviewed are either unsure or positive that the medications they prescribe for patients with chronic constipation are not working.

Key Points: 
  • The survey of roughly 100 high-volume gastroenterology providers found that 74 percent of those interviewed are either unsure or positive that the medications they prescribe for patients with chronic constipation are not working.
  • Disrupting the U.S. $4.6 billion constipation treatment market, Vibrant Gastro’s first-in-class technology offers providers and patients with a new, non-pharmaceutical alternative to address this issue.
  • Patients track the progress of the treatment on their phone with an app to increase compliance, consistency and to monitor results.
  • A study presented at Digestive Disease Week in 2023 found significant symptomatic relief in patients and a substantially improved quality of life.

The American Journal of Managed Care® (AJMC®)’s Institute for Value-Based Medicine® (IVBM®) hosts event to highlight treatment options for obesity and minimizing risk of type 2 diabetes and cardiovascular disease

Retrieved on: 
星期五, 四月 5, 2024

The Institute for Value-Based Medicine® (IVBM®) has gained recognition for advocating value-based care and advancing health care methodologies.

Key Points: 
  • The Institute for Value-Based Medicine® (IVBM®) has gained recognition for advocating value-based care and advancing health care methodologies.
  • The upcoming event will showcase a panel of health care experts engaging in discussions about the latest advancements in the fields of value-based care and population health practices.
  • The event aims to acknowledge and explore the challenges within these domains.
  • Their invaluable insights and contributions will enrich the event, making it an exceptional platform for cutting-edge discussions in the health care landscape.